Today, a jury reached a verdict in the Jones Roundup™ product liability trial before Judge Patrick P...
Farmers and growers have been using glyphosate-based herbicides safely and effectively to control weeds for more than 40 years. These products continue to play a critical role in helping farmers manage weeds and sustainably deliver crops to markets around the world.
The litigation over glyphosate primarily stems from one place: an opinion by a group called IARC. IARC is not a regulatory authority and did not conduct any original scientific studies. Yet in 2015, after IARC classified glyphosate as a “probable carcinogen,” trial attorneys in the U.S. began running advertisements to recruit plaintiffs for lawsuits against Monsanto, the manufacturer of many glyphosate-based herbicides (i.e., RoundupTM-branded herbicides). These lawsuits rely heavily on IARC’s classification, which has many significant limitations and flaws and runs counter to an extensive body of science supporting glyphosate’s safe use. More than four years after reaching its opinion, leading pesticide regulators around the world continue to conclude that glyphosate is not carcinogenic and that glyphosate-based herbicides are safe when used as directed.
The Company has a winning record in the Roundup litigation and has won ten of the last sixteen cases at trial. Three trials are currently ongoing, including Cloud in New Castle County, Delaware, which began on February 5, 2024; Cody in Conway County, Arkansas, which began on February 15; Kline in Philadelphia, which began on February 20; and Meyer in Sonoma County, California, which began on February 27.
Bayer will vigorously defend its products based on the strong body of science that confirms glyphosate and glyphosate-based products are safe when used as directed and that glyphosate does not cause cancer.